Comment on "a comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes"
To the Editor:
Tibaldi et al. report results of the propensity-matched observational CONFIRM study 1 in previously insulin-naïve adults with type 2 diabetes, comparing two second-generation basal insulins. Using patients' electronic medical records from a large US database, they report an association between treatment with insulin degludec (IDeg) and a reduction in glycated haemoglobin (HbA1c) and hypoglycaemia rates, compared with insulin glargine 300 units/mL (Gla-300).
The results are in marked contrast to previously reported comparisons of these insulins [2] [3] [4] and a recent randomized controlled trial (RCT) 5 comparing the same basal insulins in broadly the same patient population, which found equivalent effects on both HbA1c and hypoglycaemia over a 6-month treatment period. Reasonably, we might have expected to see results that were similar at least on a ratio scale.
Unfortunately, there are important flaws in the CONFIRM propensity score matching, which probably explain this discrepancy and confound any conclusions that may be drawn from the CONFIRM study.
The matching of cohorts in terms of hypoglycaemia prior to insulin initiation is clearly suboptimal (Supporting Information Table S2 ) and it is this imbalance at baseline, rather than the effects of treatment It is completely plausible that these mismatches between the patient groups, rather than differences in the treatments received by the patients, explain the results presented and these imbalances can explain why the CONFIRM results differ from the RCT results.
Real-world studies, which provide data gathered from actual patient experiences and diverse patient populations, are valuable and encouraged. 6, 7 However, while maximising external validity (generalisability), real-world studies will lack internal validity (unlike RCTs) if matching is not successful. Unfortunately, adequate matching is not achieved in the study by Tibaldi et al.
